Colletofragarone A2, isolated from the fungus Colletotrichum sp. (13S020), exhibits anti-cancer activity by inhibiting mutant p53 and HSP90. It promotes the degradation and aggregation of mutant p53, in turn suppressing tumor growth in vivo [1].